The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

A new study from the Texas A&M University School of Public Health explores a theoretical framework for implementing an ...

The poster titled “ Preclinical and Translational Pharmacokinetics of GD2-SADA, a Self-Assembling and Disassembling (SADA) Bispecific Fusion Protein for Pretargeted Radioimmunotherapy (PRIT)” ...

The condition may be tricky to spot as it overlaps with other common symptoms, including tiredness and weight gain ...

Determined to improve, I decided to challenge myself: 60 seconds of medicine ball work at the end of every workout for a week. That translated to 21 reps for me – although my training partner managed ...

We commemorate International Holocaust Remembrance Day, designated by the United Nations to mark the anniversary of the January 27, 1945 liberation of Auschwitz-Birkenau, the largest Nazi ...

Clinicians and laboratory professionals can rely on molar unit measurements to know the Lp(a) particle numbers.

Researchers stressed that taking a harm reduction approach does not condone nor subtly encourage high-risk alcohol use among college students; instead, this theoretical application allows for a ...

Terwijl het gebruik van ADHD-medicatie bij volwassenen toeneemt, is voor die behandeling volgens het digitaal tijdschrift ...

PISCATAWAY, NJ, USA I January 28, 2025 I Kashiv Biosciences, LLC, a global leader in biopharmaceutical innovation, today announced that their abatacept ...

A clinical trial has shown that an internet-delivered lifestyle intervention has resulted in significantly better cognition ...

Robert Melvin, Northeast Region Director, R Street Institute Testimony in Support of HB 2319: “Drug and controlled paraphernalia; creates exception for drug checking products.” January 28, 2025 House ...